https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-eisai-biogens-alzheimers-drug-2023-01-06/
0
0
1/7/23 at 6:10am
Organization
Reuters
Authors
The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug lecanemab developed by Eisai Co Ltd <a href="https://www.reuters.com/companies/4523.T" target="_blank">(4523.T)</a> and Biogen Inc <a href="https://www.reuters.com/companies/BIIB.O"…
Create an account
or login to join the discussion